| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |